151
Participants
Start Date
May 26, 2016
Primary Completion Date
October 31, 2017
Study Completion Date
October 31, 2017
AGN-199201 ophthalmic solution
1 drop of AGN-199201 ophthalmic solution Doses A, B, C in the eye.
AGN-190584 ophthalmic solution
1 drop of AGN-190584 ophthalmic solution Doses A, B, C in the eye.
AGN-199201 Vehicle
Vehicle to AGN-199201
AGN-190584 Vehicle
Vehicle to AGN-190584
Scott & Christie and Associates, PC, Cranberry Township
Specialized Eye Care, Baltimore
James D. Branch, Winston-Salem
Medical University of South Carolina, Charleston
Clayton Eye Center, Morrow
MedEye Associates, Miami
Center for Sight, Sarasota
Central Florida Eye Institute, Ocala
Total Eye Care, PA, Memphis
Silverstein Eye Centers, Louisville
The Eye Care Institute, Louisville
University of Texas Medical Branch, Galveston
R and R Eye Research, LLC, San Antonio
Medical Center Ophthalmology Associates, San Antonio
Cataract and Glaucoma Center, El Paso
Hoopes Durrie Rivera Research, LLC, Draper
Wolstan and Golberg Eye Associates, Torrance
WCCT Global, LLC, Cypress
Sall Research Medical Center, Artesia
Retina Institute of California Medical Group, Arcadia
Specialty Eye Care Medical Center, Glendale
Lugene Eye Institute, Glendale
The Eye Research Foundation, Newport Beach
Stanford Eye and Laser Center, Palo Alto
Devers Eye Institute, Portland
Lead Sponsor
Allergan
INDUSTRY